Act 426 of the 2019 Legislature amended the state controlled substance law to require practitioners to record certain information on certain prescriptions for opioid medications. In particular, when a practitioner prescribes a quantity of certain opioid medications in excess of a seven-day supply for certain patients, the practitioner is required to indicate on the prescription the quantity ordered is medically necessary. The Board alerted its licensees to this new law in Bulletin 19-01 issued on July 1, 2019. Since then, the Board has become aware of several misconceptions among pharmacists as to what the law requires. During their August 14, 2019 meeting, the Board directed the issuance of Bulletin 19-03 to provide further guidance about the new law to its licensees. The Board distributed Bulletin 19-03 on August 18, 2019, and a copy of it resides on the Bulletins page in the Public Library section of the Board's website.